07/25/2025
4:26 PM | Chromocell Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
07/23/2025
8:14 PM | Chromocell Therapeutics (Issuer)
Plesha Scott M. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/23/2025
8:17 PM | Chromocell Therapeutics (Issuer)
Plesha Scott M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/21/2025
7:25 PM | Chromocell Therapeutics (Issuer)
Rangarao Sai (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/21/2025
7:26 PM | Chromocell Therapeutics (Issuer)
Rangarao Sai (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/10/2025
3:15 PM | Chromocell Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
07/08/2025
3:05 PM | 3i, LP (Filed by)
Chromocell Therapeutics (Subject)
| Form SCHEDULE 13G | |
07/07/2025
8:47 PM | Baxter Richard B (Reporting)
Chromocell Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/07/2025
8:37 PM | Baxter Richard B (Reporting)
Chromocell Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/07/2025
8:39 PM | Pauls Matthew (Reporting)
Chromocell Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/07/2025
8:40 PM | Greenleaf Peter (Reporting)
Chromocell Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
Get the Latest News and Ratings for CHRO and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Chromocell Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
07/07/2025
8:41 PM | Malamut Richard (Reporting)
Chromocell Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/07/2025
8:42 PM | Friedberg Ezra M (Reporting)
Chromocell Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/07/2025
8:43 PM | Davis Todd C (Reporting)
Chromocell Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/07/2025
8:44 PM | Francis Knuettel II (Reporting)
Chromocell Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/07/2025
8:45 PM | Pauls Matthew (Reporting)
Chromocell Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/07/2025
8:46 PM | Greenleaf Peter (Reporting)
Chromocell Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2025
8:02 PM | Davis Todd C (Reporting)
Chromocell Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2025
8:04 PM | Francis Knuettel II (Reporting)
Chromocell Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2025
8:05 PM | Friedberg Ezra M (Reporting)
Chromocell Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2025
8:07 PM | Friedberg Ezra M (Filed by)
Chromocell Therapeutics (Subject)
| Form SCHEDULE 13D/A | |
07/03/2025
8:28 AM | LIGAND PHARMACEUTICALS INC (Reporting)
Chromocell Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/03/2025
8:33 AM | LIGAND PHARMACEUTICALS INC (Reporting)
Chromocell Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2025
4:22 PM | Chromocell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2025
4:30 PM | Chromocell Therapeutics (Filer)
| Form PREM14C | |
05/01/2025
4:05 PM | Chromocell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/17/2025
5:11 AM | Chromocell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/15/2025
8:30 PM | Chromocell Therapeutics (Issuer)
Francis Knuettel II (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/15/2025
8:31 PM | Chromocell Therapeutics (Issuer)
Simmons Chia-Lin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2025
4:08 PM | Chromocell Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/03/2025
6:00 AM | Chromocell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2025
12:09 PM | Chromocell Therapeutics (Subject)
Ikarian Capital, LLC (Filed by)
| Form SCHEDULE 13G | |
01/15/2025
4:27 PM | Alexandra Wood Inc. (0002052171) (Filed by)
Chromocell Therapeutics (Subject)
| Form SCHEDULE 13G | |
12/19/2024
11:15 PM | Chromocell Therapeutics (Filer)
| Form EFFECT | |
12/11/2024
3:06 PM | Chromocell Therapeutics (Filer)
| Form POS AM | |
12/02/2024
11:15 PM | Chromocell Therapeutics (Filer)
| Form EFFECT | |
11/22/2024
3:30 PM | Chromocell Therapeutics (Filer)
| Form POS AM | |
11/21/2024
8:00 AM | Chromocell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/18/2024
4:03 PM | Chromocell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/15/2024
3:19 PM | Chromocell Therapeutics (Issuer)
Friedberg Ezra M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/15/2024
3:20 PM | Chromocell Therapeutics (Issuer)
Malamut Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Your blueprint for crypto wealth (Ad) Mark August 12th on your calendar.
27 of crypto's most successful minds are about to reveal everything… Claim your pass to the Crypto Community Summit here (free for a limited time) |
11/15/2024
3:22 PM | Chromocell Therapeutics (Issuer)
Davis Todd C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2024
4:19 PM | Chromocell Therapeutics (Filer)
| Form 424B3 | |
11/13/2024
4:14 PM | Chromocell Therapeutics (Filer)
| Form 424B3 | |
11/13/2024
3:30 PM | Chromocell Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/13/2024
3:05 PM | 3i, LP (Filed by)
Chromocell Therapeutics (Subject)
| Form SC 13G/A | |
10/24/2024
7:30 AM | Chromocell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/26/2024
4:08 PM | Chromocell Therapeutics (Filer)
| Form DEF 14A | |
09/16/2024
3:55 PM | Chromocell Therapeutics (Issuer)
Francis Knuettel II (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
3:56 PM | Chromocell Therapeutics (Issuer)
Malamut Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2024
4:35 PM | Chromocell Therapeutics (Issuer)
Francis Knuettel II (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/09/2024
4:30 PM | Chromocell Therapeutics (Filer)
| Form PRE 14A | |
08/13/2024
4:23 PM | Chromocell Therapeutics (Filer)
| Form 424B3 | |
08/13/2024
4:19 PM | Chromocell Therapeutics (Filer)
| Form 424B3 | |
08/13/2024
3:31 PM | Chromocell Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/07/2024
3:50 PM | Chromocell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2024
11:15 PM | Chromocell Therapeutics (Filer)
| Form EFFECT | |
08/06/2024
3:49 PM | Chromocell Therapeutics (Filer)
| Form 424B3 | |
